Dr Max Julvé

Clinical Assistant Professor in Solid Tumour Cellular Therapy and Melanoma @StanfordCancer

[Dr Mark Lythgoe @DrMarkLythgoe]

Immunotherapy timing debate continues…

New meta-analysis in JAMA Network Open suggests morning ICI administration may improve outcomes.

Interesting signal, but mostly retrospective data with confounding risk.

@cremieuxrecueil @oncology_bg @Eddie_Cliff
https://t.co/CbW6vsXj9I

[Pauline Funchain @FunchainMD]

Strong showing from @StanfordCancer at #irAE26 💪 survivorship speaker Lydia Shapira, new solid tumor cellular therapy/melanoma faculty @JulveMax, GI and pulm representation from Karen Kim and Weijia Chua, RNs Laura M and Lisa K, APP Lucie P, tech Elizabeth P, and me ♥️ #GoCard

[Stanford Cancer Institute @StanfordCancer]

Congratulations to Pauline Funchain, associate director of training and education at the Stanford Cancer Institute, on being selected for the 2026-2027 @ASCO Leadership Development Program: Education Scholars class. https://t.co/3l6y2mCXxG @FunchainMD

[ASCO @ASCO]

Following FDA approval of lifileucel for advanced melanoma in early 2024, U.S. centers have been learning how to best deliver this novel “living” drug. For #ASCODailyNews, @JulveMax and @DrBetofMDPhD discuss the real-world challenges facing clinicians: https://t.co/iSuli4b1r0

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

Three quarters of our @StanfordCancer #melanoma medical oncology team representing at @_MDEducation Melanoma US Focus Meeting in San Diego. Great meeting to learn, build collaborations, and enhance connections in our field. @JulveMax @kimberlyloomd

[Dr Max Julvé @JulveMax]

@sophiawongyn @HaanenJohn @NKI_nl @nccsingapore @DrGopalIyer Looks epic! 👏

[Dr Max Julvé @JulveMax]

Great to finally start my clinic at @StanfordCancer ! Learning from the best in the game @DrBetofMDPhD

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

Successful first day of clinic @StanfordCancer for @JulveMax!! #melanoma #TIL #solidtumorcelltherapy

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

Loved moderating a panel @PMWCintl on challenges and opportunities with TIL therapy with Drs. @CoukosGeorge, Stephanie Goff, and @JulveMax. What a privilege to share the podium with these luminaries in the field. #PMWC26

A few days in the office/lab then next stop is #SSO2026.

[Dr Max Julvé @JulveMax]

@DrBetofMDPhD @StanfordCancer @SCIDirector @HwakeleeMD @FunchainMD 🤝

[Dr Max Julvé @JulveMax]

Happy to announce that today I start a new role as Clinical Assistant Professor in Solid Tumour Cellular Therapy and Melanoma at @StanfordCancer!

Thanks to everyone who supported me along this journey, in particular @DrBetofMDPhD @FunchainMD @HwakeleeMD

[Dr Max Julvé @JulveMax]

Congrats @ZaydTippu!! Future RCC royalty 👑

[Dr Max Julvé @JulveMax]

Great to present some of my MD(res) data here at the @sitcancer Spring Scientific in San Diego.

How do PD-L1 expressing neutrophils influence the efficacy of TIL therapy? 🧪

@ICR_London @royalmarsdenNHS @ajsfurness

[OncoDaily IO @OncoDailyIO]

Toxicity management strategies for solid tumour cell therapy - @JulveMax

https://t.co/pe7P5xEBhp

@esmo_iotech @sophiawongyn @DrJonLim @ajsfurness

#Cancer #SolidTumors #ImmuneOnc #IO #ImmunoOncology #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[Dr Max Julvé @JulveMax]

Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in @esmo_iotech .

A great team effort from @sophiawongyn @DrJonLim @ajsfurness !

https://t.co/aOM9hJAK1z

[Dr Max Julvé @JulveMax]

Great IO and cell therapy fellowship opportunity in Manchester! ⬇️⬇️

[Jon Lim, MRCP PhD @DrJonLim]

🆕 opportunity!

🧑‍⚕️Interested in novel IO & cell therapy in solid cancer? Keen to gain experience in early phase trials?

Come join Fiona, me & our amazing team as a ‘Clinical Fellow in Advanced Immunotherapy & Cell Therapy Team’.

Deadline 27 Nov 2024 👇
https://t.co/E20orxboDu

[Dr Max Julvé @JulveMax]

@A_DAlessioMD @ILCAnews @LorenzaRimassa @DJPinato Congrats!

[Dr Sophia Wong @sophiawongyn]

What a pleasure to be giving a talk with this panel on novel #immunotherapy #bispecifics #bites #cancervaccines #celltherapy with @fg_herrera @udai_banerji @ElenaGarralda Tim Yap. Thank you for the opportunity! #ESMO24

[Medical Oncologist @MiguelTICONA]

@JulveMax @MelanomaPod @cdanicas @DrSapnaPatel @royalmarsdenNHS @DuncanGilbert11 @Adam_Hexter After UK 🇬🇧 vs Peru 🇵🇪 #ESMO24 football match, thank you for your cordiality.

See you next year in #ESMO25, Berlin 🇩🇪

[Dr Max Julvé @JulveMax]

Great catching up with @DrJonLim and @sophiawongyn to discuss all things cellular therapy at #ESMO2024

[Dr Max Julvé @JulveMax]

A great evening thank you @cdanicas for organising. Congrats to team Ireland for winning against us on penalties in the final. 🇮🇪🇬🇧#ESMO24 @DuncanGilbert11 @Adam_Hexter @majbaxter @ZaydTippu